Venus Medtech (Hangzhou) Inc. Stock
Equities
2500
CNE100003PJ8
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 HKD | -0.71% | -.--% | -.--% |
04-01 | Venus Medtech Trims Loss in 2023 as Revenue Grows Nearly 21% | MT |
03-28 | Venus Medtech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2023 | 491M 67.81M 531M 92.71M | Sales 2024 * | 730M 101M 789M 138M | Capitalization | 2.26B 312M 2.44B 426M |
---|---|---|---|---|---|
Net income 2023 | -721M -99.5M -779M -136M | Net income 2024 * | -293M -40.44M -317M -55.28M | EV / Sales 2023 | 4.6 x |
Net cash position 2023 * | 410M 56.53M 443M 77.28M | Net Debt 2024 * | 125M 17.27M 135M 23.61M | EV / Sales 2024 * | 3.26 x |
P/E ratio 2023 |
-3.13
x | P/E ratio 2024 * |
-7.89
x | Employees | 865 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 73.87% |
1 day | -0.71% | ||
6 months | +34.45% |
Managers | Title | Age | Since |
---|---|---|---|
Hou-Sen Lim
CEO | Chief Executive Officer | 50 | 16-11-30 |
Fei Wang
DFI | Director of Finance/CFO | 47 | 23-01-03 |
Meirong Liu
BRD | Director/Board Member | 47 | 17-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hou-Sen Lim
CEO | Chief Executive Officer | 50 | 16-11-30 |
Ting Yuk Wu
CHM | Chairman | 69 | 18-11-25 |
Wei Wang
BRD | Director/Board Member | 41 | 18-11-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +1.11% | - | |
0.00% | 4 M€ | -4.41% | - | |
0.00% | 34 M€ | +2.14% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-.--% | 314M | |
+12.07% | 128B | |
-9.04% | 10.65B | |
+0.91% | 8.82B | |
+16.72% | 7.19B | |
+25.15% | 4.99B | |
+7.17% | 3.4B | |
-1.36% | 3.03B | |
-8.73% | 2.14B | |
-10.15% | 2B |
- Stock Market
- Equities
- 2500 Stock